Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 9Lymphoma, Follicular 4Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Graft vs Host Disease 2Ulcer 1Stomatitis 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Oral Ulcer 1Metastatic Castration-Resistant Prostate Cancer 1Melanoma 1Lymphoma, B-Cell 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Intestinal Obstruction 1Colitis, Ulcerative 1Colitis 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61pembrolizumab 60ribociclib 59Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Methylprednisolone × Clear all
NCT02229136 2022-12-01

Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus

US Oncology Research

Phase 2 Completed
104 enrolled
Breast

Breast Neoplasms, Stomatitis, Oral Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡